Clinical Trial Update: Effect of C-peptide on Hypoglycemic Counterregulation [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating whether C-peptide affects hypoglycemic counterregulation in people with type 1 diabetes and hypoglycemia, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• C-peptide (C-peptide)

Snippet

Sponsor: University of Cincinnati | Conditions: Hypoglycemia, Type 1 Diabetes | EARLY_Phase 1 | Status: RECRUITING